Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Jh-re-06-d6 | 1361227-90-8 | 98.0% | 474.75 | 1 MG
Supplier: Medchemexpress LLC HY126214S1MG
JH-RE-06-d6 is a deuterium labeled compound, derived from JH-RE-06. It functions as a potent inhibitor of the REV1-REV7 interface, targeting REV1 and disrupting mutagenic translesion synthesis. This action helps prevent the recruitment of mutagenic POLζ, thereby improving chemotherapy efficacy.
- Can be used as a tracer
- Functions as an internal standard for quantitative analysis
- Targets REV1 to disrupt mutagenic translesion synthesis
- Improves chemotherapy outcomes
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?